- $1.42bn
- $1.10bn
- $157.75m
- 75
- 17
- 76
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 46 | 85.9 | 111 | 136 | 158 |
Cost of Revenue | |||||
Gross Profit | 22.1 | 47.9 | 60 | 51.8 | 70.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 76.4 | 97.4 | 259 | 412 | 372 |
Operating Profit | -30.4 | -11.6 | -148 | -275 | -214 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -31.9 | -13.9 | -338 | -110 | -199 |
Provision for Income Taxes | |||||
Net Income After Taxes | -32 | -14 | -338 | -111 | -199 |
Net Income Before Extraordinary Items | |||||
Net Income | -32 | -14 | -338 | -111 | -199 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -32 | -14 | -338 | -111 | -199 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.741 | -0.325 | -2.58 | -0.393 | -0.653 |
Dividends per Share |